Early Pregnancy COVID-19 Linked to Heart Defect Risk
New research suggests maternal infection during early gestation may affect fetal heart development in some infants.
Updated on Oct. 30, 2026 in Heart Disease
Live Poll
Does evidence of viral-related birth risks make you more concerned about your own health during pregnancy?
A large-scale study identified an association between maternal COVID-19 infection during early gestation and an increased risk of specific congenital heart defects in infants. The findings provide new insight for individuals planning pregnancies regarding the potential impact of infection during the critical window of fetal heart development.
Why it matters
Understanding the potential developmental impacts of viral infections during early pregnancy helps clarify the importance of prenatal health precautions. This research distinguishes between infection timing, highlighting that the highest risk window occurs during early gestation rather than the periconception period.
In a retrospective cohort study of 161,731 mother-infant pairs, researchers linked maternal COVID-19 infection between 3 and 8 weeks of gestation to an increased risk of critical congenital heart disease and atrial septal defect. Notably, the study found no increased risk for vaccinated mothers.
The details
The study utilized a validated algorithm to identify major structural cardiac defects among infants born between 2020 and 2024. Maternal infection during the 3 to 8 week window of gestation coincides with the period of critical fetal heart development. While infection during this specific timeframe showed associations with cardiac issues, the research observed no such risk associated with infections occurring during the periconception period.
Timeline
January 2020 to December 2024: Conception period for study participants.
Up to 6 months before periconception: Maternal COVID-19 vaccination window.
3 to 8 weeks of gestation: Period of critical fetal heart development.
Health Landscape
This study contributes to the expanding body of research evaluating maternal-fetal health outcomes following the 2020-2024 global COVID-19 pandemic. It further refines the understanding of prenatal risks by pinpointing specific gestational windows that require clinical attention.
If you are pregnant or planning to conceive, the study results suggest that protecting against COVID-19 during the first two months of gestation is vital for fetal heart development. Discuss any concerns about infection or vaccination during early pregnancy with your obstetrician.
The takeaway
Early gestation remains a critical window for fetal development, and this study suggests a potential link between COVID-19 infection and infant heart health. Speak with your healthcare provider about appropriate preventive measures if you are planning a pregnancy or are currently expecting.
Further reading
For more on managing cardiovascular health, visit our Heart Disease section.
Source note: This article includes information reported by Derm Immuno Today.
Live Poll
Does evidence of viral-related birth risks make you more concerned about your own health during pregnancy?
